CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy. nork Serwanga, J, Mugaba, S, Betty, A, Pimego, E, Walker, A, Munderi, P, Gilks, C, Gotch, F, Grosskurth, H, Kaleebu, P

Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy. nork Kikaire, B, Khoo, S, Walker, A, Ssali, F, Munderi, P, Namale, L, Reid, A, Gibb, D, Mugyenyi, P, Grosskurth, H

Patterns of sexual behaviour in a rural population in north-western Tanzania. nork Munguti, K, Grosskurth, H, Newell, J, Senkoro, K, Mosha, F, Todd, J, Mayaud, P, Gavyole, A, Quigley, M, Hayes, R

The impact of different CD4 cell-count monitoring and switching strategies on mortality in HIV-infected African adults on antiretroviral therapy: an application of dynamic marginal... nork Ford, D, Robins, JM, Petersen, ML, Gibb, DM, Gilks, CF, Mugyenyi, P, Grosskurth, H, Hakim, J, Katabira, E, Babiker, A, Walker, A

Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa. nork Stöhr, W, Reid, A, Walker, A, Ssali, F, Munderi, P, Mambule, I, Kityo, C, Grosskurth, H, Gilks, C, Gibb, D, Hakim, J

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine... nork Munderi, P, Walker, A, Kityo, C, Babiker, A, Ssali, F, Reid, A, Darbyshire, J, Grosskurth, H, Mugyenyi, P, Gibb, D, Gilks, C

The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal... nork Ford, D, Robins, J, Petersen, M, Gibb, D, Gilks, C, Mugyenyi, P, Grosskurth, H, Hakim, J, Katabira, E, Babiker, A, Walker, A

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria nork Gilks, C, Walker, A, Munderi, P, Kityo, C, Reid, A, Katabira, E, Goodall, R, Grosskurth, H, Mugyenyi, P, Hakim, J, Gibb, D

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. nork Mugyenyi, P, Walker, A, Hakim, J, Munderi, P, Gibb, D, Kityo, C, Reid, A, Grosskurth, H, Darbyshire, J, Ssali, F, Bray, D, Katabira, E, Babiker, A, Gilks, C, Grosskurth, H, Munderi, P, Kabuye, G, Nsibambi, D, Kasirye, R, Zalwango, E, Nakazibwe, M, Kikaire, B, Nassuna, G, Massa, R, Fadhiru, K

Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. nork Obasi, A, Mosha, F, Quigley, M, Sekirassa, Z, Gibbs, T, Munguti, K, Todd, J, Grosskurth, H, Mayaud, P, Changalucha, J, Brown, D, Mabey, D, Hayes, R

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART coh... nork Walker, A, Ford, D, Gilks, C, Munderi, P, Ssali, F, Reid, A, Katabira, E, Grosskurth, H, Mugyenyi, P, Hakim, J, Darbyshire, J, Gibb, D, Babiker, A

Higher risk behaviour and rates of sexually transmitted diseases in Mwanza compared to Uganda may help explain HIV prevention trial outcomes. nork Orroth, K, Korenromp, E, White, R, Gavyole, A, Gray, R, Muhangi, L, Sewankambo, N, Quigley, M, Wawer, M, Whitworth, J, Grosskurth, H, Habbema, J, Hayes, R

Sexual behaviour patterns and other risk factors for HIV infection in rural Tanzania: a case-control study. nork Quigley, M, Munguti, K, Grosskurth, H, Todd, J, Mosha, F, Senkoro, K, Newell, J, Mayaud, P, ka-Gina, G, Klokke, A, Mabey, D, Gavyole, A, Hayes, R

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. nork Ssali, F, Stöhr, W, Munderi, P, Reid, A, Walker, A, Gibb, D, Mugyenyi, P, Kityo, C, Grosskurth, H, Hakim, J, Byakwaga, H, Katabira, E, Darbyshire, J, Gilks, C

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial. nork Gibb, D, Kizito, H, Russell, E, Chidziva, E, Zalwango, E, Nalumenya, R, Spyer, M, Tumukunde, D, Nathoo, K, Munderi, P, Kyomugisha, H, Hakim, J, Grosskurth, H, Gilks, C, Walker, A, Musoke, P

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretro... nork Ross, LL, Walker, AS, Lou, Y, Tenorio, AR, Gibb, DM, Double, J, Gilks, C, McCoig, CC, Munderi, P, Musoro, G, Kityo, CM, Grosskurth, H, Hakim, J, Mugyenyi, PN, Cutrell, A, Perger, T, Shaefer, MS

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe nork Lara, A, Kigozi, J, Amurwon, J, Muchabaiwa, L, Wakaholi, B, Mota, R, Walker, A, Kasirye, R, Ssali, F, Reid, A, Grosskurth, H, Babiker, A, Kityo, C, Katabira, E, Munderi, P, Mugyenyi, P, Hakim, J, Darbyshire, J, Gibb, D, Gilks, C, DARTT Team